Completed
Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients
NCT02028442
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +20 more
- Locations
-
- GZA ziekenhuizen campus Sint-Augustinus Wilrijk, Antwerp, Belgium
- Cliniques Universitaires St Luc Brussels, Belgium
- Ghent University Hospital Ghent, Belgium
- Institut Catala d Oncologica Barcelona, Spain